216 related articles for article (PubMed ID: 15050339)
1. Deformable image registration for the use of magnetic resonance spectroscopy in prostate treatment planning.
Wu X; Dibiase SJ; Gullapalli R; Yu CX
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1577-83. PubMed ID: 15050339
[TBL] [Abstract][Full Text] [Related]
2. Interactive deformation registration of endorectal prostate MRI using ITK thin plate splines.
Cheung MR; Krishnan K
Acad Radiol; 2009 Mar; 16(3):351-7. PubMed ID: 19201364
[TBL] [Abstract][Full Text] [Related]
3. Narrow band deformable registration of prostate magnetic resonance imaging, magnetic resonance spectroscopic imaging, and computed tomography studies.
Schreibmann E; Xing L
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):595-605. PubMed ID: 15890605
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging.
Zelefsky MJ; Cohen G; Zakian KL; Dyke J; Koutcher JA; Hricak H; Schwartz L; Zaider M
Cancer J; 2000; 6(4):249-55. PubMed ID: 11038145
[TBL] [Abstract][Full Text] [Related]
5. A feasibility study to investigate the use of thin-plate splines to account for prostate deformation.
Venugopal N; McCurdy B; Hnatov A; Dubey A
Phys Med Biol; 2005 Jun; 50(12):2871-85. PubMed ID: 15930608
[TBL] [Abstract][Full Text] [Related]
6. Proton MR spectroscopy of the prostate.
Mueller-Lisse UG; Scherr MK
Eur J Radiol; 2007 Sep; 63(3):351-60. PubMed ID: 17709223
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer: value of magnetic resonance spectroscopy 3D chemical shift imaging.
Casciani E; Gualdi GF
Abdom Imaging; 2006; 31(4):490-9. PubMed ID: 16955379
[TBL] [Abstract][Full Text] [Related]
8. [1H magnetic resonance spectroscopy of the prostate].
Mueller-Lisse UG; Scherr M
Radiologe; 2003 Jun; 43(6):481-8. PubMed ID: 12827263
[TBL] [Abstract][Full Text] [Related]
9. Mapping of the prostate in endorectal coil-based MRI/MRSI and CT: a deformable registration and validation study.
Lian J; Xing L; Hunjan S; Dumoulin C; Levin J; Lo A; Watkins R; Rohling K; Giaquinto R; Kim D; Spielman D; Daniel B
Med Phys; 2004 Nov; 31(11):3087-94. PubMed ID: 15587662
[TBL] [Abstract][Full Text] [Related]
10. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer.
van Dorsten FA; van der Graaf M; Engelbrecht MR; van Leenders GJ; Verhofstad A; Rijpkema M; de la Rosette JJ; Barentsz JO; Heerschap A
J Magn Reson Imaging; 2004 Aug; 20(2):279-87. PubMed ID: 15269954
[TBL] [Abstract][Full Text] [Related]
11. Combined MRI and MRS in prostate cancer: improvement of spectral quality by susceptibility matching.
Scheidler J; Vogel M; Gross P; Heuck A
Rofo; 2009 Jun; 181(6):531-5. PubMed ID: 19353482
[TBL] [Abstract][Full Text] [Related]
12. Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging.
Pouliot J; Kim Y; Lessard E; Hsu IC; Vigneron DB; Kurhanewicz J
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1196-207. PubMed ID: 15234056
[TBL] [Abstract][Full Text] [Related]
13. Automatic segmentation of pelvic structures from magnetic resonance images for prostate cancer radiotherapy.
Pasquier D; Lacornerie T; Vermandel M; Rousseau J; Lartigau E; Betrouni N
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):592-600. PubMed ID: 17498571
[TBL] [Abstract][Full Text] [Related]
14. Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study.
Kumar R; Nayyar R; Kumar V; Gupta NP; Hemal AK; Jagannathan NR; Dattagupta S; Thulkar S
Urology; 2008 Oct; 72(4):859-63. PubMed ID: 18329078
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging and magnetic resonance spectroscopic imaging of prostate cancer.
Huzjan R; Sala E; Hricak H
Nat Clin Pract Urol; 2005 Sep; 2(9):434-42. PubMed ID: 16474681
[TBL] [Abstract][Full Text] [Related]
16. Using manual prostate contours to enhance deformable registration of endorectal MRI.
Cheung MR; Krishnan K
Comput Methods Programs Biomed; 2012 Oct; 108(1):330-7. PubMed ID: 22333512
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
Kurhanewicz J; Vigneron DB; Hricak H; Narayan P; Carroll P; Nelson SJ
Radiology; 1996 Mar; 198(3):795-805. PubMed ID: 8628874
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional conformal external beam radiotherapy compared with permanent prostate implantation in low-risk prostate cancer based on endorectal magnetic resonance spectroscopy imaging and prostate-specific antigen level.
Pickett B; Kurhanewicz J; Pouliot J; Weinberg V; Shinohara K; Coakley F; Roach M
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):65-72. PubMed ID: 16517094
[TBL] [Abstract][Full Text] [Related]
19. Automated detection of prostatic adenocarcinoma from high-resolution ex vivo MRI.
Madabhushi A; Feldman MD; Metaxas DN; Tomaszeweski J; Chute D
IEEE Trans Med Imaging; 2005 Dec; 24(12):1611-25. PubMed ID: 16350920
[TBL] [Abstract][Full Text] [Related]
20. Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging.
Coakley FV; Chen I; Qayyum A; Westphalen AC; Carroll PR; Hricak H; Chen MH; Kurhanewicz J
BJU Int; 2007 Jan; 99(1):41-5. PubMed ID: 17227490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
